Migraine Treatment Using Erenumab: Can Lead to a Cognitive and Psychological Qualitative Improvement?

Migraine is one of the most disabling disorders in the world, associated with poor quality of life. Migraine prevention strategies have increasingly evolved since monoclonal antibodies against the calcitonin gene-related peptide (CGRP), or its receptor, were identified. CGRP is the ideal target of m...

Descripción completa

Detalles Bibliográficos
Autores principales: Torrisi, Michele, Corallo, Francesco, Lo Buono, Viviana, Di Cara, Marcella, Grugno, Rosario, Lo Presti, Riccardo, Quartarone, Angelo, De Cola, Maria Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222452/
https://www.ncbi.nlm.nih.gov/pubmed/37241168
http://dx.doi.org/10.3390/medicina59050936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222452/
https://www.ncbi.nlm.nih.gov/pubmed/37241168
http://dx.doi.org/10.3390/medicina59050936

Ejemplares similares